Épidémiologie de la maladie alcoolique et nouveaux enjeux, 2009. ,
Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study, Hepatology, vol.23, pp.1025-1034, 1996. ,
Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group, Gut, vol.41, pp.845-50, 1997. ,
, An International Group. Alcoholir Liver Disease: Morphological Manifestations. The Lancet, vol.317, pp.707-718, 1981.
Alcoholic hepatitis: clinicopathologic features and therapy, Semin Liver Dis, vol.8, pp.91-102, 1988. ,
Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features, Aliment Pharmacol Ther, vol.25, pp.1047-54, 2007. ,
Corticoid therapy in the treatment of acute alcoholic hepatitis. Results of a meta-analysis, Gastroenterol Clin Biol, vol.15, pp.223-231, 1991. ,
Corticosteroid therapy of alcoholic hepatitis, Gastroenterology, vol.75, pp.193-202, 1978. ,
Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial, Ann Intern Med, vol.110, pp.685-90, 1989. ,
Corticosteroids for alcoholic hepatitis-what's next?, Journal of Hepatology, vol.43, pp.526-559, 2005. ,
Practice Guideline Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease, Hepatology, vol.51, pp.307-335, 2010. ,
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH, J Hepatol, vol.36, pp.480-487, 2002. ,
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis, N Engl J Med, vol.365, pp.1781-1790, 2011. ,
Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score, Gut, vol.54, pp.1174-1183, 2005. ,
A new scoring system for prognostic stratification of patients with alcoholic hepatitis, Am J Gastroenterol, vol.103, pp.2747-56, 2008. ,
Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?, Aliment Pharmacol Ther, vol.22, pp.1079-89, 2005. ,
Model for end-stage liver disease (MELD) and allocation of donor livers, Gastroenterology, vol.124, pp.91-97, 2003. ,
MELD accurately predicts mortality in patients with alcoholic hepatitis, Hepatology, vol.41, pp.353-361, 2005. ,
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis, J Hepatol, vol.42, pp.700-706, 2005. ,
Is histology required for the diagnosis of alcoholic hepatitis? a review of published randomised controlled trials, Gut, vol.60, pp.233-233, 2011. ,
, Management of Alcohol-Related Liver Disease
,
A histologic scoring system for prognosis of patients with alcoholic hepatitis, Gastroenterology, vol.146, pp.1-6, 2014. ,
1152 Severe Acute alcoholic hepatitis (AAH) in France in 2008: Nationwide survey results (AFEF, ANGH, SNFMI), Journal of Hepatology, vol.52, p.445, 2010. ,
Mid-infrared spectroscopy of serum, a promising non-invasive method to assess prognosis in patients with ascites and cirrhosis, PLoS ONE, vol.12, p.185997, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01625051
Mid-Infrared spectroscoy has a high sensitivity and specificity by Dr, Rodolphe Anty. Disponible sur ,
Surgery and portal hypertension, Major Probl Clin Surg, vol.1, pp.1-85, 1964. ,
The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids, Hepatology, vol.45, pp.1348-54, 2007. ,
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach, Biometrics, vol.44, pp.837-882, 1988. ,
The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease, J Hepatol, vol.44, pp.1175-85, 2006. ,
Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic Hepatitis, PLoS ONE, vol.10, p.134302, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01225004
Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis, J Hepatol, vol.32, pp.412-420, 2000. ,
Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans, Hepatology, vol.60, pp.1291-301, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02875319
1 H NMR-based serum metabolic profiling in compensated and decompensated cirrhosis, World J Gastroenterol, vol.18, pp.285-90, 2012. ,
Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis, J Hepatol, vol.64, pp.1058-67, 2016. ,
1H NMR spectroscopy for the prediction of therapeutic outcome in patients with fulminant hepatic failure, NMR Biomed, vol.19, pp.521-527, 2006. ,